1. Home
  2. BCRX vs ENOV Comparison

BCRX vs ENOV Comparison

Compare BCRX & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • ENOV
  • Stock Information
  • Founded
  • BCRX 1986
  • ENOV 1995
  • Country
  • BCRX United States
  • ENOV United States
  • Employees
  • BCRX N/A
  • ENOV N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • ENOV Fluid Controls
  • Sector
  • BCRX Health Care
  • ENOV Industrials
  • Exchange
  • BCRX Nasdaq
  • ENOV Nasdaq
  • Market Cap
  • BCRX 1.9B
  • ENOV 1.6B
  • IPO Year
  • BCRX 1994
  • ENOV 2008
  • Fundamental
  • Price
  • BCRX $8.45
  • ENOV $28.82
  • Analyst Decision
  • BCRX Strong Buy
  • ENOV Strong Buy
  • Analyst Count
  • BCRX 10
  • ENOV 6
  • Target Price
  • BCRX $16.70
  • ENOV $51.00
  • AVG Volume (30 Days)
  • BCRX 3.5M
  • ENOV 1.5M
  • Earning Date
  • BCRX 08-04-2025
  • ENOV 08-07-2025
  • Dividend Yield
  • BCRX N/A
  • ENOV N/A
  • EPS Growth
  • BCRX N/A
  • ENOV N/A
  • EPS
  • BCRX N/A
  • ENOV N/A
  • Revenue
  • BCRX $557,506,000.00
  • ENOV $2,189,576,000.00
  • Revenue This Year
  • BCRX $37.96
  • ENOV $8.23
  • Revenue Next Year
  • BCRX $8.82
  • ENOV $6.18
  • P/E Ratio
  • BCRX N/A
  • ENOV N/A
  • Revenue Growth
  • BCRX 45.85
  • ENOV 14.40
  • 52 Week Low
  • BCRX $6.02
  • ENOV $25.47
  • 52 Week High
  • BCRX $11.31
  • ENOV $49.83
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 46.82
  • ENOV 50.23
  • Support Level
  • BCRX $8.08
  • ENOV $25.72
  • Resistance Level
  • BCRX $8.64
  • ENOV $30.31
  • Average True Range (ATR)
  • BCRX 0.33
  • ENOV 1.19
  • MACD
  • BCRX 0.06
  • ENOV 0.45
  • Stochastic Oscillator
  • BCRX 43.90
  • ENOV 69.21

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: